SkyWater Signs Production Agreement with Nautilus Biotechnology to Fabricate Novel Biomedical Devices - Seite 2

“As we continue to experience growth in our innovation-focused ATS development business, we are pleased to see one of our development-stage life science customers begin their transition to Wafer Services production. Our TaaS model allows customers to continue to innovate for future designs on the same tools and processes as their current product, enabling a ‘lab-to-fab' environment,” said Ross Miller, SVP, Commercial and A&D Business at SkyWater. “We look forward to continuing to support Nautilus as they move toward the commercial availability of their groundbreaking proteome analysis platform. It’s exciting to be working with their team on efforts to revolutionize biomedicine and positively impact the health and lives of people around the world.”

About SkyWater Technology

SkyWater (NASDAQ: SKYT) is a U.S.-based semiconductor manufacturer and a DMEA-accredited Category 1A Trusted Foundry. SkyWater’s Technology as a Service model streamlines the path to production for customers with development services, volume production and heterogeneous integration solutions in its world-class U.S. facilities. This pioneering model enables innovators to co-create the next wave of technology with diverse categories including mixed-signal CMOS, read-out ICs, rad-hard ICs, power management, MEMS, superconducting ICs, photonics, carbon nanotubes and interposers. SkyWater serves growing markets including aerospace & defense, automotive, biomedical, cloud & computing, consumer, industrial and IoT. For more information, visit: www.skywatertechnology.com.

SkyWater Technology Forward-Looking Statements

This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements that are based on the Company’s current expectations or forecasts of future events, rather than past events and outcomes, and such statements are not guarantees of future performance. Forward-looking statements are subject to risks, uncertainties and assumptions, which may cause the Company’s actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Key factors that could cause the Company’s actual results to be different than expected or anticipated include, but are not limited to, factors discussed in the “Risk Factors” section of its annual report on Form 10-K and quarterly reports on Form 10-Q, and in other documents that the Company files with the SEC, which are available at http://www.sec.gov. The Company assumes no obligation to update any forward-looking statements, which speak only as of the date of this press release.